MedTrace Logo

PK Study of ACHN-490 Injection in Renally Impaired Subjects

NCT01462136 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2012-08-23

No results posted yet for this study

Summary

The purposes of this study is to assess the relationship between renal function and pharmacokinetics of ACHN-490 Injection.

Conditions

  • Renal Insufficiency

Interventions

DRUG

ACHN-490 Injection

7.5 mg/kg single dose administered intravenously over 30 minutes

Sponsors & Collaborators

Principal Investigators

  • Medical Director · Achaogen, Inc.

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-09-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01462136 on ClinicalTrials.gov